Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib helped regrow hair in most patients with severe hair loss.

High-dose interferon is effective for chronic hepatitis C but often causes flu-like symptoms.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Alefacept does not effectively treat severe alopecia areata.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.